| Hepatitis/HIV Project |
 |
| about TAG |
|
| TAGline |
|
| activism & policy |
|
| TB/HIV project |
|
| science & vaccines |
|
| antiretrovirals |
|
| search |
|
The Treatment Action Group's Hepatitis/HIV Project collaborates with activists, community members, scientists, government, and drug companies to make life-saving information, prevention, and safer, more tolerable, and more effective treatment for viral hepatitis and HIV available to all people who need it. It forges coalitions with activists worldwide to demand universal access to prevention, care and treatment for viral hepatitis and HIV.
The Hepatitis/HIV Project fights for research to address the unmet needs of people who are coinfected with viral hepatitis and HIV, focusing on better treatment, and a cure. It works domestically and internationally, with activists, community members, the US Food and Drug Administration (FDA), and the European Medicines Evaluation Agency (EMEA) to urge the pharmaceutical industry to study drugs and treatment strategies among people coinfected with HIV, African-Americans, people with advanced liver disease, current and former drug users, and people unresponsive to existing treatments.
[ home ] [ what's new ] [ current reports ] [ policy ] [ articles ] [ links ] [ archives ]
- Hepatitis C: new treatments in the pipeline
- ADAP coverage chart by state of hepatitis treatments and supportive therapies
Hepatitis A (HAV) & Hepatitis B (HBV) vaccines, Hepatitis C treatment, growth factors, & selective serotonin reuptake inhibitors (SSRIs) (updated 4/21/2008) - Final Report: Research Agenda and Access to Experimental HCV Drugs for Coinfected People. An International Workshop Report (added 1/02/08)
- Guide to Hepatitis C for People Living With HIV | To order hard copies
Testing, coinfection, treatment, support - from first questions and dealing with a new diagnosis, to treatment for HCV and living with coInfection. - Sitges Statement on HIV/HCV Coinfection
A meeting in Spain addresses the clinical development of novel HCV therapies for HIV/HCV coinfected people.
- The Hepatitis C (HCV) Treatment Pipeline
chapter from full report also in pdf format
- Hepatitis C Virus (HCV) and HIV/HCV Coinfection: A Critical Review of Research and Treatment
- HCV/HIV Drugs in Development Pipeline 2004
- Sitges Statement on HIV/HCV Coinfection
A meeting in Spain addresses the clinical development of novel HCV therapies for HIV/HCV coinfected people. - ADAP coverage chart by state of hepatitis treatments and supportive therapies
Hepatitis A (HAV) & Hepatitis B (HBV) vaccines, Hepatitis C treatment, growth factors, & selective serotonin reuptake inhibitors (SSRIs) - SCH 503034 trials exclude African-American participants
Open letter protests exclusionary study design (added 4/21/2006) - Sign-on letters addressing HCV funding to Senate and House Sub-committees on Appropriations
- HCV and liver transplantation
Regardless of HIV status, transplant candidates face a daunting shortage of livers - Research and Policy Recommendations for Hepatitis C Virus (HCV)/HIV Coinfection
Critical Issues from TAG's forthcoming HCV/HIV Coinfection Report, version 2.0 - TAGline January 2005. Taylor-ed Treatment: Brown University Clinician Leads the Way in Providing Competent Care to Coinfected Injectors
- TAGline June 2004. Expert Panel's Decision To Recommend Against Routine HCV Screening Draws Community Ire
- TAGline April 2004. Sustained Virologic Responses in ACTG A5071, APRICOT and ANRS HC02 (RIBAVIC)
- TAGline February 2004. Proliferation of Polymerase Inhibitors and Others Tales from the HCV Crypt
- TAGline December 2003. Expediency, Cost-Cutting Trump Science In Peg-Intron Clinical Development Plan
Archived Articles
- A review of 'Management of Hepatitis C: 2002 Draft Consensus Statement'
by Daniel Raymond (6/25/2002) - HIV/HCV COINFECTION: Amid swirling controversy the profile of a killer emerges
by Michael Marco - Position paper regarding approval of Hoffmann-La Roche's valganciclovir
by Michael Marco - Roche's valganciclovir is recommended for approval
by Michael Marco - The Hepatitis Report: A Critical Review of the Research and Treatment of Hepatitis C Virus (HCV) and Hepatitis & HIV Coinfection
by Michael Marco Jeffrey Schouten, M.D. - HIV & Hepatitis C Virus (HCV) Coinfection: 7th Retrovirus Conference Update
by Michael Marco
- 1998 OIs Report. Also, zipped Word Perfect version for downloading
- TAG Does ICAAC by Mark Harrington and Michael Marco
AIDS research highlights from the 35th Interscience Conference on Antimicrobial Agents & Chemotherapy (ICAAC), San Francisco, California, September 17-20, 1995. zipped Word version for downloading - The Lymphoma Project Report by Michael Marco
Current issues in the research and treatment of AIDS-associated lymphoma. Written for the 31st Annual Meeting American Society of Clinical Oncology Los Angeles, CA, May 20-23, 1995. zipped Word version for downloading - The KS Project Report by Michael Marco with Martin Majchrowicz
Current issues in research and treatment of Kaposi's sarcoma. Written for the eighteenth AIDS Clinical Trials Group Meeting Washington, D.C., July 25,1994. zipped Word version for downloading
Each of these papers is available in hard copy format by writing or calling TAG at the address and numbers below. Please note that all papers provided here are dated. While the information contained in them is important, treatment options have changed since the dates of their writing.
TAG papers are provided here in zipped text-only format for downloading and reading with a text editor. If you don't have an unzip application, you can download shareware called pkunzip for DOS, WinZip for Windows, or Zipit for Macs. Extract the zipped program onto your harddrive and associate the zip extension with the application both in your browser and on your harddrive. Then when you click on a zipped file to download, your harddrive will automatically unzip the file and you'll be able to read it with whatever text reader or word processing application you use.
TAG index